Differences in accumulation of anthracyclines daunorubicin, doxorubicin and epirubicin in rat tissues revealed by immunocytochemistry

Histochemistry and Cell Biology

Volumn 133, Issue 6, 2010, Pages 677-682

  Shin, Masashi ^a   Matsunaga, Hayato Matsunaga ^a   Fujiwara, Kunio ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Accumulation; Daunorubicin; Doxorubicin; Epirubicin; Immunocytochemistry; Kidney; P glycoprotein; Rat

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HAIR FOLLICLE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CELL; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; STOMACH;

ANIMALS; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; MALE; RATS; RATS, WISTAR;

RATTUS;

EID: 77954533071     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-010-0700-3     Document Type: Article

References (32)

1. Arcamone F, Penco S, Vigevani A et al (1975) Synthesis and antitumor properties of new glycosides of daunorubicinone and adriamycinone. J Med Chem 18:703-707
2. Basser RL, Green MD (1993) Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat Rev 19:57-77
3. Blum RH (1975) An overview of studies with adriamycin (NSC) in the United States. Cancer Chemother Rep 6:247
4. Blum RH, Carter SK (1974) Adriamycin: a new anticancer drug with signiWcant clinical activity. Ann Intern Med 80:249-259
5. Bonfante V, Bonadonna G, Villani F et al (1979) Preliminary phase I study of 4β-epi-adriamycin. Cancer Treat Rep 63:915-918
6. Calendi E, Dimarco A, Reigiani M (1965) On physico-chemical interactions between daunomycin and nucleic acid. Biochim Biophys Acta 103:25-49
7. Camaggi CM, Comparsi R, Strocchi E, Testoni F, Angelelli B, Pannuti F (1988) Epirubicin and doxorubicin comparative metabolism and pharmacokinetics: a cross-over study. Cancer Chemother Pharmacol 21:221-228
8. Chabner BA, Ryan DP, Paz-Ares L, Carbonero RG, Calabresi P (2001) Antineoplastic agents. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, p 1389
9. Di Marco A, Gaetani M, Dorigotti L, Soldati M, Bellini O (1963) Studi sperimentali sull attivita antineoplastica del nuovo antibiotico daunomicina. Tumori 49:203-217
10. Frederick CA, Williams LD, Ughetto G, van der Marel GA, Wang AH (1990) Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry 13:2538-2549
11. Fujiwara K, Takatsu H, Tsukamoto K (2005) Immunocytochemistry for drugs containing an aliphatic amino group in the molecule, anticancer antibiotic daunomycin as a model. J Histochem Cytochem 53:467-474
12. Fujiwara K, Shin M, Hougaard DM, Larsson L-I (2007) Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem Cell Biol 127(1):69-77
13. Fujiwara K, Shin M, Matsunaga H, Saita T, Larsson L-I (2009) Lightmicroscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney. Antimicrob Agents Chemother 53:3302-3307
14. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multi-drug transporter. Annu Rev Biochem 62:385-427
15. Graham RC, Karnovsky NJ (1966) The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14:291-302
16. Iliskovic N, Hasinoff BB, Malisza KL, Li T, Danelisen I, Singal PK (1999) Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. Mol Cell Biochem 196:43-49
17. Lipscomb LA, Peek ME, Zhou FX, Bertrand JA, VanDerveer D, Williams LD (1994) Water ring structure at DNA interfaces: hydration and dynamics of DNA-anthracycline complexes. Biochemistry 33:3649-3659
18. Martini A, Moro E, Pacciarini MA, Tamassia V, Natale N, Piazza E (1984) Cross-over study of pharmacokinetics and haematological toxicity of 4β-epi-doxorubicin and doxorubicin in cancer patients. Int J Clin Pharmacol Res 4:231-238
19. Montilla P, Tunez I, Munoz MC, Lopez A, Soria JV (1997) Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 76:345-350 (Pubitemid 27296539)
20. Neidle S (1977) A hypothesis concerning possible new derivatives of daunorubicin and adriamycin with enhanced DNA-binding properties. Cancer Treat Rep 61(5):928-929
21. Ohara K, Shin M, Larsson LI, Fujiwara K (2007a) Improved immunocytochemical detection of daunomycin. Histochem Cell Biol 127(6):603-608
22. Ohara K, Shin M, Nakamuta H, Larsson LI, Hougaard DM, Fujiwara K (2007b) Immunocytochemical studies on the distribution pattern of daunomycin in rat gastrointestinal tract. Histochem Cell Biol 128:285-290
23. Pohle W, Flemming J (1986) Interaction of the C14 group of adriamycin with DNA phosphate as spectroscopically evidenced. J Biomol Struct Dyn 4:243-250
24. Quigley GJ, Wang AH, Ughetto G, van der Marel G, van Boom JH, Rich A (1980) Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). Proc Natl Acad Sci 77:7204-7208
25. Ramanathan-Girish S, Boroujerdi M (2001) Contradistinction between doxorubicin and epirubicin: in vitro interaction with blood components. J Pharm Pharmacol 53:815-821
26. Schaub TP, Kartenbeck J, Konig J, Vogel O, Witzgall R, Kriz W, Keppler D (1997) Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8:1213-1221 (Pubitemid 27493625)
27. Shin M, Larsson L-I, Hougaard DM, Fujiwara K (2009) Daunomycin accumulation and induction of programmed cell death in rat hair follicles. Cell Tissue Res 337:429-438
28. Speth PA, Linssen PC, Termond EF, Boezeman JB, Wessels HM, Haanen C (1989) In vivo and in vitro pharmacokinetic differences between four structurally closely related anthracyclines in hematopoietic cell subtypes in humans. Drug Metab Dispos 17:98-105
29. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48:1926-1929
30. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738
31. Zhang J, Clark JR, Herman EH, Ferrans VJ (1996) Doxorubicininduced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931-1943
32. Zima T, Tesar V, Stipek S, Crkovska J, Poledne R, Teminova J, Platenik J, Rychlik I, Merta M, Nemeek K (1997) The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 75:464-468